Recent

% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dr.kuvasz dr.kuvasz Apr 20, 2010 7:20 AM Flag

    Cash if you're out there:

    here is my view on provenge

    1. it will get approved

    2. will sell in USA

    3. revenues for global blockbuster of cancer drug is 500ml; in fact the chemos sell at 2 bill worldwide

    4. manufacturing process/treatment limited to 3 centres in USA

    5. assuming satisfactory link between these centres and patients, and coverage by insurers, what would be annual sales in USA

    6 current market cap of 5 bil. isn't that what the company is worth assuming smooth manufacturing and sales?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 2B revenues = a 20 B MC---145.00+_ PPS--possible folks!` GL

      • 1 Reply to ejparchitect1
      • good luck. I wish I had bought DNDN last summer. I don't know if I would have sold by now, never know until in that position.

        I guess DNDN has to wait to see a) global success and b) how much can be manufactured and sold in US. I cannot see the rest of the world supporting provenge on a cost/efficacy argument. I don't know if 2 bl will be revenue in US.

        OGXI is not a competitor to provenge. The more people live, the more 011 will be used. And people live longer and for their families.

        I like watching the DNDN board. lots of nuts and lots to learn from.

 
OGXI
1.00-0.0200(-1.96%)May 26 3:59 PMEDT